PT  - JOURNAL ARTICLE
AU  - Kurita, Junko
AU  - Sugawara, Tamie
AU  - Ohkusa, Yasushi
TI  - Effect of emergency declaration for the COVID-19 outbreak in Tokyo, Japan in the first two weeks
AID  - 10.1101/2020.04.16.20067447
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.16.20067447
4099  - http://medrxiv.org/content/early/2020/04/23/2020.04.16.20067447.short
4100  - http://medrxiv.org/content/early/2020/04/23/2020.04.16.20067447.full
AB  - Background Japan’s Prime Minister Abe declared an emergency to control the COVID-19 outbreak on April 7, 2020. He asked almost half of the population of Japan to reduce their personal contacts by 70–80%.Object This study estimates the effectiveness of that emergency declaration. Method: We applied a simple susceptible–infected–recovery model to data of patients with symptoms in Tokyo, Japan for January 14 – April 21 as of April 22. We estimate the reproduction number in four periods: R0 before voluntary event cancellation and school closure (VECSC) which was introduced since February 27 to March 19, Rv during the VECSC, Ra after VECSC, and Re after the emergency declaration.Results Results suggest that the value of R0 was estimated as 1.267; its range was [1.214, 1.341]. However, Rv was estimated as 2.360 [1.844, 2.623]. Ra was estimated as 2.307 [2.035, 2.794] and Re was 0.462 [0.347, 0.514].Discussion and Concussion One must be reminded that these results reflect only those at two weeks after the emergency declaration. The reproduction number probably changed thereafter continuously.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases. (in Japanese) https://www.mhlw.go.jp/stf/newpage_10723.html